Alembic Pharmaceuticals share price rose in the opening trade on June 8 after the company signed a shareholders' agreement to invest in a newly incorporated Canadian entity, Canada Inc., aimed at ...

AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...

Counter-Strike 2 is a 5v5 competitive FPS featuring two opposing teams: Terrorist (T) and Counter-Terrorist (CT). You'll play the first half of the match on one team, then the two teams will swap over ...

Welcome to Stationery Week on the Strategist, where we’ve been obsessively researching and testing office supplies — everything from pens, pencils, and paper to task chairs. For more, head to our ...

Looking for a new fitness routine this January? Start here. Credit...Janelle Jones for The New York Times Supported by By Erik Vance Each week this January, the Well team will suggest a program of ...

From Ironmouse to IShowSpeed, content creators of all stripes are finding success as streamers. Professional streamers often have elaborate setups that can cost thousands of dollars. You may not use ...

Linux has long been known as the operating system of developers and power users, but today it’s far more accessible than ever before. Thanks to user-friendly distributions that prioritize simplicity, ...

Whether you prioritize sporty riding or comfort, a sense of adventure or a bare-bones approach with an affordable price, there are a lot of motorcycles for beginners to choose from these days.

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...